Last Updated: June 24, 2026

List of Excipients in API methylprednisolone


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing methylprednisolone

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Pharmacia & Upjohn Company LLC MEDROL methylprednisolone 0009-0049 CALCIUM STEARATE
Pharmacia & Upjohn Company LLC MEDROL methylprednisolone 0009-0049 LACTOSE
Pharmacia & Upjohn Company LLC MEDROL methylprednisolone 0009-0049 MINERAL OIL
Pharmacia & Upjohn Company LLC MEDROL methylprednisolone 0009-0049 SORBIC ACID
Pharmacia & Upjohn Company LLC MEDROL methylprednisolone 0009-0049 STARCH, CORN
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Start Trial

Excipients in ANDA-approved (generic) drugs containing methylprednisolone

Company Ingredient NDC Excipient
Endo USA Inc methylprednisolone 0603-4593 CELLULOSE, MICROCRYSTALLINE
Endo USA Inc methylprednisolone 0603-4593 MAGNESIUM STEARATE
Endo USA Inc methylprednisolone 0603-4593 SODIUM STARCH GLYCOLATE TYPE A POTATO
Sandoz Inc methylprednisolone 0781-5022 CELLULOSE, MICROCRYSTALLINE
Sandoz Inc methylprednisolone 0781-5022 LACTOSE MONOHYDRATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Start Trial

Detailed excipient profiles for methylprednisolone

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BENZYL ALCOHOL

Excipient focus: CALCIUM STEARATE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: HYDROCHLORIC ACID

Excipient focus: HYPROMELLOSE 2910

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MINERAL OIL

Excipient focus: MIRIPIRIUM CHLORIDE

Excipient focus: MYRISTYL-.GAMMA.-PICOLINIUM CHLORIDE

Excipient focus: PEG-20 SORBITAN OLEATE

Excipient focus: PEG-75

Excipient focus: POLACRILIN POTASSIUM

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYSORBATE 80

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM PHOSPHATE DIBASIC DIHYDRATE

Excipient focus: SODIUM PHOSPHATE, DIBASIC

methylprednisolone drug variants containing SODIUM PHOSPHATE, DIBASIC

Company Ingredient NDC
Pharmacia & Upjohn Company LLC methylprednisolone acetate 0009-0274
Pharmacia & Upjohn Company LLC methylprednisolone sodium succinate 0009-0698
Pharmacia & Upjohn Company LLC methylprednisolone sodium succinate 0009-0758
Hikma Pharmaceuticals USA Inc methylprednisolone sodium succinate 0143-9754
Rebel Distributors Corp methylprednisolone acetate 21695-952
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: SODIUM PHOSPHATE, MONOBASIC

Excipient focus: SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS

methylprednisolone drug variants containing SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS

Company Ingredient NDC
Pharmacia & Upjohn Company LLC methylprednisolone sodium succinate 0009-0698
Pharmacia & Upjohn Company LLC methylprednisolone sodium succinate 0009-0758
Hikma Pharmaceuticals USA Inc methylprednisolone sodium succinate 0143-9182
Hikma Pharmaceuticals USA Inc methylprednisolone sodium succinate 0143-9754
Hikma Pharmaceuticals USA Inc methylprednisolone sodium succinate 0143-9850
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: SORBIC ACID

Excipient focus: STARCH, CORN

Excipient focus: STEARIC ACID

Excipient focus: SUCROSE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links